Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostatHAZNEDAROGLU, Berat Z; BEYAZIT, Yavuz; WALKER, Sharon L et al.Critical reviews in oncology/hematology. 2012, Vol 83, Num 1, pp 21-34, issn 1040-8428, 14 p.Article

Marine pharmacology in 2001-2: antitumour and cytotoxic compoundsMAYER, Alejandro M. S; GUSTAFSON, Kirk R.European journal of cancer (1990). 2004, Vol 40, Num 18, pp 2676-2704, issn 0959-8049, 29 p.Article

Impact of rapamycin on liver regenerationPALMES, Daniel; ZIBERT, Andree; BUDNY, Tymotheus et al.Virchows Archiv. 2008, Vol 452, Num 5, pp 545-557, issn 0945-6317, 13 p.Article

Degradation of antineoplastic cytarabine in aqueous solution by gamma radiationOCAMPO-PEREZ, R; RIVERA-UTRILLA, J; SANCHEZ-POLO, M et al.Chemical engineering journal (1996). 2011, Vol 174, Num 1, pp 1-8, issn 1385-8947, 8 p.Article

Preclinical efficacy spectrum and pharmacokinetics of ixabepiloneLEE, Francis Y. F; SMYKLA, Richard; JOHNSTON, Kathy et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 2, pp 201-212, issn 0344-5704, 12 p.Article

Anticancer drugs in surface waters What can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs?BESSE, Jean-Philippe; LATOUR, Jean-François; GARRIC, Jeanne et al.Environment international. 2012, Vol 39, Num 1, pp 73-86, issn 0160-4120, 14 p.Article

Phytochemistry, nutritional and pharmacological properties of Artocarpus heterophyllus Lam (jackfruit): A reviewMANJESHWAR SHRINATH BALIGA; ARNADI RAMACHANDRAYYA SHIVASHANKARA; HANIADKA, Raghavendra et al.Food research international. 2011, Vol 44, Num 7, pp 1800-1811, issn 0963-9969, 12 p.Article

Marine pharmacology in 2005-2006 : Antitumour and cytotoxic compoundsMAYER, Alejandro M. S; GUSTAFSON, Kirk R.European journal of cancer (1990). 2008, Vol 44, Num 16, pp 2357-2387, issn 0959-8049, 31 p.Article

Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapySTONE, Everett; CHANTRANUPONG, Lynne; GONZALEZ, Candice et al.Journal of controlled release. 2012, Vol 158, Num 1, pp 171-179, issn 0168-3659, 9 p.Article

Synthetic and Application Perspectives of Azapodophyllotoxins: Alternative Scaffolds of PodophyllotoxinKUMAR, A; KUMAR, V; ALEGRIA, A. E et al.Current medicinal chemistry. 2011, Vol 18, Num 25, pp 3853-3870, issn 0929-8673, 18 p.Article

Synthesis, characterisation and cytotoxicity of chloro derivatives of prenylnaphthohydroquinoneMOLINARI, Aurora; OLIVA, Alfonso; OJEDA, Claudia et al.Bioorganic & medicinal chemistry. 2005, Vol 13, Num 11, pp 3841-3846, issn 0968-0896, 6 p.Article

Reevaluating the Accelerated Approval Process for Oncology DrugsWILSON, Wyndham H; SCHENKEIN, David P; JERNIGAN, Cheryl L et al.Clinical cancer research (Print). 2013, Vol 19, Num 11, pp 2804-2809, issn 1078-0432, 6 p.Article

Hydrallmanol A, an interesting diphenyl-p-menthane derivative of mixed biogenetic origin from the hydroid Hydrallmania falcataPATHIRANA, C; ANDERSEN, R. J; WRIGHT, J. C. L et al.Tetrahedron letters. 1989, Vol 30, Num 12, pp 1487-1490, issn 0040-4039, 4 p.Article

Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancerFUKS, J. Z; PATEL, H; VAN ECHO, D. A et al.Medical and pediatric oncology. 1985, Vol 13, Num 2, pp 73-77, issn 0098-1532Article

Antineoplastic activity of esters and amides of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-aminoacidsZELLER, W. J; EHRESMANN, K; EISENBRAND, G et al.Journal of cancer research and clinical oncology. 1984, Vol 108, Num 2, pp 249-251, issn 0171-5216Article

DrugsCancer chemotherapy. 1984, Num 6, pp 1-199Article

Determination of panaxytriol, a new type of tumour growth inhibitor from Panax ginseng, by capillary gas chromatographyMATSUNAGA, H; KATANO, M; YAMAMOTO, H et al.Journal of chromatography. 1989, Vol 481, pp 368-372, issn 0021-9673, 5 p.Article

Tricyclic heteroatomatic systems. 1,2,3,4-tetrahydropyrazolo[4,3-c][1]benzazepin-1-ones as potential antitumor agentsPALAZZINO, G; CECCHI, L; COLOTTA, V et al.Journal of heterocyclic chemistry. 1989, Vol 26, Num 1, pp 71-75, issn 0022-152X, 5 p.Article

Effects of clinical combinations of antileukemic drugs on DNA ligase from human thymocytes and normal, stimulated, or leukemic lymphocytesLAMBALLE, F; MANIEY, D; BOSCHER, M.-Y et al.Leukemia. 1988, Vol 2, Num 6, pp 363-370, issn 0887-6924Article

Differential reactivity of 9-NH₂-ellipticine on apurinic and apyrimidinic sites in circular DNAMALVY, C; BERTRAND, J. R.FEBS letters. 1986, Vol 208, Num 1, pp 155-157, issn 0014-5793Article

Analytical DNA flow cytometric analysis of deoxyadenosine toxicity in cultured human leukemic lymphoblastsFOX, R. M; TRIPP, E. H; TAYLOR, I. W et al.Molecular pharmacology. 1984, Vol 26, Num 2, pp 388-394, issn 0026-895XArticle

Pharmacological investigations on lodinamineCIOLI, V; CORRADINO, C; DE MARTINO, C et al.Arzneimittel-Forschung. 1984, Vol 34, Num 4, pp 455-460, issn 0004-4172Article

Ultrastructural observations on the vincristine-induced neuronal crystalloid inclusion in young ratsSATO, M; MIYOSHI, K.Acta neuropathologica. 1984, Vol 63, Num 2, pp 150-159, issn 0001-6322Article

The antiproliferative effect of suramin on the cancer cell line SW-13 is mediated by the inhibition of transforming growth factor β1 (TGF-β1) : IV meeting of the inter-regional group Abruzzo, Lazio, Molise, Toscana, Umbria of the Italian Society of Pharmacology, Pisa, March 11, 1991DANESI, R; AGEN, C; BERNARDINI, N et al.Pharmacological research. 1992, Vol 25, pp 17-18, issn 1043-6618, SUP1Conference Paper

Circadian tolerance to etoposide and cisplatin as first line treatment for advanced lung carcinomaFOCAN, C; BASTENS, B; DRIESSCHAERT, P et al.Annual review of chronopharmacology. 1990, Vol 7, pp 219-222, issn 0743-9539, 4 p.Conference Paper